Treatment Considerations and Role of Trimodal Therapy in Bladder Cancer

The bladder transplant procedure involved a collaboration between the University of California, Los Angeles and the University of Southern California.

Zeyad Schwen, MD, a urologic oncologist at Cleveland Clinic, discusses how patient factors and cancer characteristics are key to deciding between focal therapies and whole gland treatment for prostate cancer.

The phase 3 RC48-C016 trial met its primary end points.

In this episode, Ashish M. Kamat, MD, MBBS, highlights the state of bladder cancer care in recognition of Bladder Cancer Awareness Month.

Data showed that physical function and self-reported frailty assessments were poorly correlated.

The Oncologic Drugs Advisory Committee meeting is scheduled for May 21, 2025.